Daesung Microbiological Labs대성미생물
036480 · KOSDAQ · ₩036480 · 대성미생물
₩5,490▼ ₩20 (0.36%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 19.9% | 24.8% | 17.0% | 19.0% | 18.8% | 23.9% |
| Operating margin | −2.6% | 2.7% | −6.5% | −2.7% | −1.3% | 1.4% |
| Net margin | 3.1% | 2.3% | −7.4% | −2.7% | 6.7% | 3.6% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | −3.1% | +9.2% | −6.9% | +0.2% | +6.3% | — |
| Operating income growth | −193.4% | +146.0% | −125.2% | −110.4% | −197.2% | — |
| Net income growth | +31.6% | +133.8% | −160.3% | −139.9% | +96.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 2.3% | 1.7% | −4.9% | −1.8% | 4.5% | 2.3% |
| Return on assets | 1.4% | 1.0% | −2.9% | −1.1% | 2.7% | 1.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 65.9% | 63.7% | 66.1% | 72.1% | 67.6% | 69.2% |
| Net debt to equity | 21.6% | 15.8% | 28.7% | 26.7% | 46.3% | 47.7% |
| Current ratio | 351.0% | 295.8% | 521.8% | 276.2% | 270.4% | 446.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Daesung Microbiological Labs / 대성미생물 / 036480 / KRX:036480
Source: KRX statistical information